Search details
1.
Lower Body Negative Pressure: Physiological Effects, Applications, and Implementation.
Physiol Rev
; 99(1): 807-851, 2019 01 01.
Article
in English
| MEDLINE | ID: mdl-30540225
2.
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.
N Engl J Med
; 384(11): 1003-1014, 2021 03 18.
Article
in English
| MEDLINE | ID: mdl-33730454
3.
Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305).
AIDS Behav
; 26(12): 4107-4114, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-35687192
4.
Effect of aging on H-reflex response to fatigue.
Exp Brain Res
; 238(2): 273-282, 2020 Feb.
Article
in English
| MEDLINE | ID: mdl-31844912
5.
Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial.
Ann Intern Med
; 167(6): 384-393, 2017 Sep 19.
Article
in English
| MEDLINE | ID: mdl-28828489
6.
Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305).
J Infect Dis
; 215(2): 238-246, 2017 Jan 15.
Article
in English
| MEDLINE | ID: mdl-27811319
7.
HPTN 068: A Randomized Control Trial of a Conditional Cash Transfer to Reduce HIV Infection in Young Women in South Africa-Study Design and Baseline Results.
AIDS Behav
; 20(9): 1863-82, 2016 09.
Article
in English
| MEDLINE | ID: mdl-26891839
8.
Infographic. Does foot mobility affect the outcome in the management of patellofemoral pain with foot orthoses versus hip exercises? A randomised clinical trial.
Br J Sports Med
; 55(5): 281-282, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-33028585
9.
Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study).
Trials
; 25(1): 124, 2024 Feb 15.
Article
in English
| MEDLINE | ID: mdl-38360750
10.
A Randomised Clinical Trial of the Safety and Pharmacokinetics of VRC07-523LS Administered via Different Routes and Doses (HVTN 127/HPTN 087).
medRxiv
; 2024 Jan 11.
Article
in English
| MEDLINE | ID: mdl-38260276
11.
Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial.
Lancet
; 379(9812): 221-8, 2012 Jan 21.
Article
in English
| MEDLINE | ID: mdl-22196945
12.
Initial clinical evaluation of a non-contrast-enhanced MR angiography method in the distal lower extremities.
Magn Reson Med
; 70(6): 1644-52, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-23440691
13.
Protein-plastic interactions: The driving forces behind the high affinity of a carbohydrate-binding module for polyethylene terephthalate.
Sci Total Environ
; 870: 161948, 2023 Apr 20.
Article
in English
| MEDLINE | ID: mdl-36739021
14.
Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01.
Nat Commun
; 14(1): 7813, 2023 Nov 28.
Article
in English
| MEDLINE | ID: mdl-38016958
15.
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials.
Nat Commun
; 14(1): 8299, 2023 Dec 14.
Article
in English
| MEDLINE | ID: mdl-38097552
16.
Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition.
EBioMedicine
; 93: 104590, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37300931
17.
Transforming Capillary Alginate Gel (Capgel) into New 3D-Printing Biomaterial Inks.
Gels
; 8(6)2022 Jun 14.
Article
in English
| MEDLINE | ID: mdl-35735720
18.
Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants.
Hum Vaccin Immunother
; 18(1): 1908030, 2022 12 31.
Article
in English
| MEDLINE | ID: mdl-34213402
19.
Infusion Reactions After Receiving the Broadly Neutralizing Antibody VRC01 or Placebo to Reduce HIV-1 Acquisition: Results From the Phase 2b Antibody-Mediated Prevention Randomized Trials.
J Acquir Immune Defic Syndr
; 89(4): 405-413, 2022 04 01.
Article
in English
| MEDLINE | ID: mdl-34923559
20.
Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition.
Nat Med
; 28(9): 1924-1932, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35995954